Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Is yervoy covered by medicare?

See the DrugPatentWatch profile for yervoy

Does Medicare Cover Yervoy?


Yes, Medicare covers Yervoy (ipilimumab), a Bristol Myers Squibb immunotherapy drug used for melanoma and other cancers, primarily under Medicare Part B as an outpatient drug administered by a doctor.[1] Coverage requires medical necessity, confirmed by a physician's documentation.

Which Medicare Parts Cover It?


- Part B: Covers Yervoy infusions in clinics or hospitals at 80% of the Medicare-approved amount after the Part B deductible ($240 in 2024). Patients pay 20% coinsurance, which can total thousands per treatment cycle due to high list prices (around $155,000 for a full melanoma course).[2][1]
- Part D: Does not typically cover infused drugs like Yervoy; it focuses on self-administered prescriptions.[1]
- Part A: May cover it during inpatient hospital stays if needed.

No coverage under Medicare Advantage (Part C) varies by plan, but most follow Part B rules.

What Affects Coverage and Costs?


Prior authorization is often required to confirm FDA-approved uses (e.g., advanced melanoma, renal cell carcinoma with nivolumab).[3]
Out-of-pocket costs average $30,000+ per year before assistance, though Yervoy has no patient assistance cap for eligible Medicare enrollees via Bristol Myers' program.[4]
Medigap (supplemental) policies can reduce the 20% coinsurance.

How Does Coverage Compare to Similar Cancer Drugs?


| Drug | Medicare Part | Typical Coverage Notes |
|------|---------------|-----------------------|
| Yervoy (ipilimumab) | Part B | Infusion only; high coinsurance |
| Opdivo (nivolumab, often combined with Yervoy) | Part B | Same as Yervoy[3] |
| Keytruda (pembrolizumab) | Part B | Similar; broader indications[1] |
| Oral targeted therapies (e.g., Zelboraf) | Part D | Lower infusion costs but different copays |

When Might Medicare Deny Coverage?


Denials occur for off-label use without strong evidence, experimental settings, or lack of prior auth. Appeals succeed in about 80% of cancer drug cases via Medicare processes.[5] Patients over 65 or with ESRD qualify automatically if eligible.

[1]: Medicare.gov - Drugs Covered by Medicare Part B
[2]: CMS - Medicare Coverage Database
[3]: FDA - Yervoy Label
[4]: Bristol Myers Squibb Patient Assistance
[5]: KFF - Medicare Drug Denials



Other Questions About Yervoy :

How can i apply for yervoy financial aid? When does yervoy's discount expire? How much can i save with yervoy discount? How does yervoy's efficacy compare to other immunotherapies? What other drugs are safe with yervoy? Will generic versions of yervoy lower its price? Will yervoy's patent expiry bring significant cost relief?




DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy